Facing pushback from some industry groups and members of Congress, the FDA offered testimony and a report making the case for the agency’s proposed increased oversight of laboratory-developed tests (LDTs) — in vitro diagnostic (IVD) tests designed, manufactured and used within a single clinical laboratory. The FDA intends to develop a regulatory framework for LDTs that “enco... Read More